首页> 外文期刊>Breast cancer research and treatment. >Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.
【24h】

Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.

机译:与雌激素和孕激素受体状态相关的乳腺癌风险的成年人体重增加:一项荟萃分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Adult weight gain is positively associated with postmenopausal breast cancer and inversely associated with premenopausal breast cancer risk. To date, no meta-analysis has been conducted to assess this association by estrogen receptor (ER) and progesterone receptor (PR) status. We searched PubMed for relevant studies published through March 2010. Summarized risk estimates (REs) with 95% confidence intervals (CIs) were calculated using random effects or fixed effects models. We retrieved nine articles on weight gain from adulthood to reference age and ER- and/or PR-defined breast cancer risk, reporting on three prospective cohort studies and eight case-control studies. Comparing the highest versus the lowest categories of adult weight gain, risk was increased for ER(+)PR(+) and ER(+) tumors combined (11 studies; RE = 2.03; 95% CI 1.62, 2.45). Statistically significant heterogeneity (p (heterogeneity) = 0.002) was shown between REs for a mixed population of pre- and postmenopausal women combined (4 studies; RE = 1.54; 95% CI 0.86, 2.22) and for postmenopausal women only (7 studies; RE = 2.33; 95% CI 2.05, 2.60). Risk for ER(-)PR(-) tumors among postmenopausal women was also slightly increased (7 studies; RE = 1.34; 95% CI 1.06, 1.63), but statistically significantly different from risk for ER(+)PR(+) tumors (p (heterogeneity) < 0.0001). No associations were observed for ER(+)PR(-) tumors whereas risk for ER(-)PR(+) tumors could not be assessed. In conclusion, the association between adult weight gain and postmenopausal breast cancer risk is heterogeneous according to ER/PR status and stronger for ER(+)PR(+) than for ER(-)PR(-) tumors.
机译:成人体重增加与绝经后乳腺癌呈正相关,与绝经前乳腺癌风险呈负相关。迄今为止,尚未进行荟萃分析来评估雌激素受体(ER)和孕激素受体(PR)的状态。我们在PubMed中搜索了直到2010年3月为止发表的相关研究。使用随机效应或固定效应模型计算了具有95%置信区间(CI)的汇总风险估计(RE)。我们检索了9篇关于从成年到参考年龄的体重增加以及ER和/或PR定义的乳腺癌风险的文章,报告了三项前瞻性队列研究和八项病例对照研究。比较成人体重增加的最高类别和最低类别,合并ER(+)PR(+)和ER(+)肿瘤的风险增加(11研究; RE = 2.03; 95%CI 1.62,2.45)。在绝经前和绝经后妇女的混合人群中,RE之间存在统计学差异(p(异质性)= 0.002)(4个研究; RE = 1.54; 95%CI 0.86,2.22)和仅对绝经后妇女(7个研究; p = 0.02)。 RE = 2.33; 95%CI 2.05,2.60)。绝经后女性中ER(-)PR(-)肿瘤的风险也略有增加(7项研究; RE = 1.34; 95%CI 1.06,1.63),但在统计学上与ER(+)PR(+)肿瘤的风险显着不同(p(异质性)<0.0001)。没有观察到ER(+)PR(-)肿瘤的关联,而无法评估ER(-)PR(+)肿瘤的风险。总之,根据ER / PR状况,成人体重增加与绝经后乳腺癌风险之间的关联是异质的,并且ER(+)PR(+)比ER(-)PR(-)肿瘤更强。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号